A dose-escalation study of vorinostat in combination with radiotherapy for patients with non-small cell lung cancer

被引：0
|
作者：
Decker, R. H. [1 ]
Gettinger, S. N. [1 ]
Wilson, L. D. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps286
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS286
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small cell lung cancer (NSCLC): A Phase I dose-escalation study
    Tredaniel, J.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J.
    Gachard, E.
    Garcia-Vargas, J.
    Roben, E.
    Zalcman, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study
    Decker, R. H.
    Gettinger, S. N.
    Glazer, P. M.
    Wilson, L. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S574 - S575
  • [3] VORINOSTAT, A HISTONE DEACETYLASE INHIBITOR, IN COMBINATION WITH THORACIC RADIOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A DOSE ESCALATION STUDY
    Decker, Roy H.
    Gettinger, Scott N.
    Glazer, Peter M.
    Wilson, Lynn D.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1550 - S1551
  • [4] Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy
    Panettieri, Vanessa
    Malik, Zafar I.
    Eswar, Chinnamani V.
    Landau, David B.
    Thornton, John M. C.
    Nahum, Alan E.
    Mayles, W. Philip M.
    Fenwick, John D.
    RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 418 - 424
  • [5] Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)
    Teixeira, L.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J. L.
    Gachard, E.
    Rizvi, S.
    Roben, E.
    Zalcman, G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 554 - 554
  • [6] Vorinostat in combination with gemcitabine plus platinum in patients with advanced non-small-cell lung cancer: A phase I, dose-escalation study
    Misset, J.
    Tredaniel, J.
    Descourt, R.
    Morot-Sibilot, D.
    Zalcman, G.
    Gachard, E.
    Garcia-Vargas, J.
    Rizvi, S.
    Reiser, D.
    Roben, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase I dose-escalation study of thoracic radiotherapy in combination with gefitinib in patients with IIIB/IV non-small cell lung cancer (NCT00497250)
    Fan, M.
    Xie, L.
    Xu, X.
    Zhang, G.
    Chen, J.
    Fu, X.
    Zhou, X.
    Li, W.
    Jiang, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose-Escalation Trial
    Modlin, L. A.
    Choi, C. Y. H.
    Gibbs, I. C.
    Wakelee, H. A.
    Neal, J.
    Pinder-Schenck, M. C.
    Chang, S. D.
    Adler, J. R.
    Harsh, G. R.
    Soltys, S. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S178 - S178
  • [9] Phase I Dose Escalation Study of Thoracic Radiotherapy in Combination with Gefitinib in Patients with IIIB/IV Non-small Cell Lung Cancer
    Chen, J.
    Fan, M.
    Jiang, G.
    Fu, X.
    Xie, L.
    Xu, X.
    Zhang, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S110 - S111
  • [10] Accurate prediction of PTV and OAR doses for dose-escalation of non-small cell lung cancer patients
    Petit, S.
    Troost, E. G. C.
    Van Elmpt, W.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S127 - S128
12345